TY  - GEN
AU  - Ferris,R L
AU  - Haddad,R
AU  - Even,C
AU  - Tahara,M
AU  - Dvorkin,M
AU  - Ciuleanu,T E
AU  - Clement,P M
AU  - Mesia,R
AU  - Kutukova,S
AU  - Zholudeva,L
AU  - Daste,A
AU  - Caballero-Daroqui,J
AU  - Keam,B
AU  - Vynnychenko,I
AU  - Lafond,C
AU  - Shetty,J
AU  - Mann,H
AU  - Fan,J
AU  - Wildsmith,S
AU  - Morsli,N
AU  - Fayette,J
AU  - Licitra,L
TI  - Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study
SN  - 1569-8041
PY  - 2021///0106
KW  - Antibodies, Monoclonal
KW  - Antibodies, Monoclonal, Humanized
KW  - therapeutic use
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Head and Neck Neoplasms
KW  - drug therapy
KW  - Humans
KW  - Neoplasm Recurrence, Local
KW  - Squamous Cell Carcinoma of Head and Neck
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.annonc.2020.04.001
ER  -